Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros













Base de datos
Intervalo de año de publicación
1.
Exp Suppl ; 108: 321-341, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-30536178

RESUMEN

Mutations in inflammasome genes are responsible for rare monogenic and polygenic autoinflammatory diseases. On the other side, genetic polymorphisms in the same molecules contribute to the development of common multifactorial diseases (i.e., autoimmune diseases, cardiovascular pathologies, cancer). In this chapter we depicted the current knowledge about inflammasome genetics.


Asunto(s)
Inflamasomas/genética , Enfermedades Autoinmunes/genética , Enfermedades Cardiovasculares/genética , Humanos , Mutación , Neoplasias/genética , Polimorfismo Genético
2.
Immunotherapy ; 10(10): 871-885, 2018 08.
Artículo en Inglés | MEDLINE | ID: mdl-30073900

RESUMEN

AIMS: A therapeutic vaccine based on monocyte-derived dendritic cells (MDDCs) has been shown to represent a promising strategy for the treatment of cancer and viral infections. Here, we characterized the MDDCs used as an immunogen in a clinical trial for an anti-HIV-1 therapeutic vaccine. PATIENTS & METHODS: Monocytes obtained from 17 HIV-infected individuals were differentiated into MDDCs and, after loading with autologous HIV, the cells were characterized concerning surface molecule expression, migratory and phagocytosis capacity, cytokine production and the induction of an effective cell-mediated immune response. RESULTS: The MDDCs were able to induce antigen-specific responses in autologous CD4+ and CD8+ T lymphocytes. CONCLUSIONS: Despite a large interindividual variability, the results suggested that MDDCs present the potential to promote immune responses in vaccinated patients.


Asunto(s)
Vacunas contra el SIDA/inmunología , Linfocitos T CD4-Positivos/inmunología , Linfocitos T CD8-positivos/inmunología , Células Dendríticas/inmunología , Infecciones por VIH/inmunología , Adulto , Femenino , VIH-1 , Humanos , Inmunoterapia/métodos , Técnicas In Vitro , Masculino , Persona de Mediana Edad , Monocitos/citología , Monocitos/inmunología , Adulto Joven
3.
Cancer Genet ; 209(10): 474-480, 2016 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-27810076

RESUMEN

Sporadic melanoma malignancy is correlated with constitutive secretion of IL-1ß in transformed melanocytes suggesting the involvement of inflammasome in melanoma. Common variants in inflammasome genes are known to affect IL-1ß expression. To investigate the contribution of inflammasome genetics in melanoma development and progression and to identify a potential prognostic marker, the distribution of selected inflammasome SNPs was analysed in a Brazilian case/control cohort of sporadic malignant melanoma (SMM) and then the expression of inflammasome components was evaluated in melanoma biopsies. Allele and gene-specific Taqman assays were implied for genotyping of case/control DNA samples and for relative expression analysis in skin biopsies respectively. CARD8 rs6509365 was found to be significantly more common in healthy volunteers than in SMM patients suggesting a protection effect of this variant towards melanoma development. Accordingly, CARD8 expression was found to be reduced in nevus compared to melanoma biopsies. Upon stratification, NLRP1 rs11651270 and CARD8 rs2043211 were found associated with nodular melanoma; IL1B rs1143643 to a lower value of Breslow index; IL18 rs5744256 to melanoma development in sun sensitive individuals. As expected, IL1B expression was up-regulated in tumour biopsies especially in metastatic samples, whereas IL18 was down-regulated compared to nevus. Our results demonstrated for the first time the contribution of inflammasome genes CARD8, IL1B and IL18 in SMM.


Asunto(s)
Proteínas Adaptadoras de Señalización CARD/genética , Predisposición Genética a la Enfermedad , Inflamasomas/genética , Interleucina-18/genética , Interleucina-1beta/genética , Melanoma/genética , Proteínas de Neoplasias/genética , Polimorfismo de Nucleótido Simple/genética , Anciano , Alelos , Biomarcadores de Tumor/genética , Brasil , Estudios de Casos y Controles , Progresión de la Enfermedad , Femenino , Estudios de Seguimiento , Genotipo , Humanos , Metástasis Linfática , Masculino , Melanoma/inmunología , Melanoma/secundario , Persona de Mediana Edad , Invasividad Neoplásica , Estadificación de Neoplasias , Pronóstico , Factores de Riesgo , Neoplasias Cutáneas/genética , Neoplasias Cutáneas/inmunología , Neoplasias Cutáneas/patología , Melanoma Cutáneo Maligno
4.
PLoS Negl Trop Dis ; 9(2): e0003520, 2015 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-25675375

RESUMEN

Dengue fever induces a robust immune response, including massive T cell activation. The level of T cell activation may, however, be associated with more severe disease. In this study, we explored the level of CD8+ T lymphocyte activation in the first six days after onset of symptoms during a DENV2 outbreak in early 2010 on the coast of São Paulo State, Brazil. Using flow cytometry we detected a progressive increase in the percentage of CD8+ T cells in 74 dengue fever cases. Peripheral blood mononuclear cells from 30 cases were thawed and evaluated using expanded phenotyping. The expansion of the CD8+ T cells was coupled with increased Ki67 expression. Cell activation was observed later in the course of disease, as determined by the expression of the activation markers CD38 and HLA-DR. This increased CD8+ T lymphocyte activation was observed in all memory subsets, but was more pronounced in the effector memory subset, as defined by higher CD38 expression. Our results show that most CD8+ T cell subsets are expanded during DENV2 infection and that the effector memory subset is the predominantly affected sub population.


Asunto(s)
Linfocitos T CD8-positivos/inmunología , Dengue/inmunología , Memoria Inmunológica/inmunología , Activación de Linfocitos/inmunología , Subgrupos de Linfocitos T/inmunología , ADP-Ribosil Ciclasa 1/metabolismo , Adulto , Anticuerpos Antivirales/sangre , Anticuerpos Antivirales/inmunología , Brasil , Linfocitos T CD4-Positivos/inmunología , Proliferación Celular , Virus del Dengue/clasificación , Virus del Dengue/inmunología , Femenino , Citometría de Flujo , Antígenos HLA-DR/metabolismo , Humanos , Antígeno Ki-67/metabolismo , Leucocitos Mononucleares/inmunología , Recuento de Linfocitos , Masculino , Glicoproteínas de Membrana/metabolismo , Persona de Mediana Edad , Adulto Joven
5.
Immunotherapy ; 5(12): 1305-11, 2013 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-24283841

RESUMEN

AIMS: HIV-1 expanded in an allogenic system (Al-HIV) represents a cheaper and faster alternative to the autologous virus (Au-HIV) as an antigen in anti-HIV immunotherapy. In this study, chemically inactivated HIV-1 obtained through autologous or allogenic systems were compared. PATIENTS & METHODS: Au-HIV and Al-HIV obtained from cultures of peripheral blood mononuclear cells from 11 HIV(+) individuals were tested for virus production, yield and time of culture, and their ability to elicit a specific immune response in vitro. RESULTS: The allogenic system was more efficient than the autologous system. Dendritic cells pulsed with Au-HIV and Al-HIV presented a similar phenotypic profile, but only Al-HIV induced a significant increase in IFN-γ(+) lymphocytes. CONCLUSION: The use of an allogenic system displays several advantages in terms of cell manipulation, time and cost of culture, and immunogenicity.


Asunto(s)
Donantes de Sangre , Infecciones por VIH/sangre , VIH-1/inmunología , Leucocitos Mononucleares/inmunología , Replicación Viral/inmunología , Vacunas contra el SIDA/inmunología , Vacunas contra el SIDA/uso terapéutico , Complejo CD3/inmunología , Complejo CD3/metabolismo , Linfocitos T CD4-Positivos/inmunología , Linfocitos T CD4-Positivos/metabolismo , Linfocitos T CD8-positivos/inmunología , Linfocitos T CD8-positivos/metabolismo , Células Cultivadas , Técnicas de Cocultivo , Células Dendríticas/inmunología , Citometría de Flujo , Infecciones por VIH/prevención & control , Infecciones por VIH/virología , VIH-1/crecimiento & desarrollo , Humanos , Interferón gamma/inmunología , Interferón gamma/metabolismo , Leucocitos Mononucleares/virología , Activación de Linfocitos/inmunología
6.
PLoS One ; 5(7): e11811, 2010 Jul 28.
Artículo en Inglés | MEDLINE | ID: mdl-20676363

RESUMEN

Dengue viruses (DENV) serotypes 1, 2, and 3 have been causing yearly outbreaks in Brazil. In this study, we report the re-introduction of DENV2 in the coast of São Paulo State. Partial envelope viral genes were sequenced from eighteen patients with dengue fever during the 2010 epidemic. Phylogenetic analysis showed this strain belongs to the American/Asian genotype and was closely related to the virus that circulated in Rio de Janeiro in 2007 and 2008. The phylogeny also showed no clustering by clinical presentation, suggesting that the disease severity could not be explained by distinct variants or genotypes. The time of the most recent common ancestor of American/Asian genotype and the São Paulo and Rio de Janeiro (SP/RJ) monophyletic cluster was estimated to be around 40 and 10 years, respectively. Since this virus was first identified in Brazil in 2007, we suggest that it was already circulating in the country before causing the first documented outbreak. This is the first description of the 2010 outbreak in the State of São Paulo, Brazil, and should contribute to efforts to control and monitor the spread of DENVs in endemic areas.


Asunto(s)
Virus del Dengue/fisiología , Dengue/epidemiología , Dengue/virología , Brasil/epidemiología , Virus del Dengue/clasificación , Virus del Dengue/genética , Brotes de Enfermedades/estadística & datos numéricos , Humanos , Filogenia , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA